keyword
https://read.qxmd.com/read/38392924/off-label-immunosuppressant-drugs-in-solid-organ-transplantation
#21
REVIEW
Rita Nogueiras-Álvarez, María Del Mar García-Sáiz
Once a solid organ transplantation (SOT) has been performed, it is necessary to prescribe immunosuppressant medication to prevent graft rejection. This task has the peculiarity that many of these drugs do not have specific indications for transplant use in the technical data sheets. We performed a review of different immunosuppressive drugs' information available at European and American regulatory agencies in order to analyze the approved indications by the type of SOT. In our work, besides showing these differences between different indication approvals in different SOT modalities, we also attempted to reflect other differences under the approved indications according to age group, formulation type, geographical area, etc...
January 22, 2024: Pharmacy (Basel, Switzerland)
https://read.qxmd.com/read/38379309/safety-and-feasibility-of-opening-tamsulosin-capsules-for-enteral-feeding-tube-administration
#22
JOURNAL ARTICLE
Victoria Fazio, Jerry Altshuler, Yong-Bum Song
Purpose: Tamsulosin is formulated as sustained release beads within a capsule to prevent rapid absorption and associated hypotension. The package insert advises the capsule is swallowed whole; not crushed, chewed, or opened. To our knowledge, there are no current data on opening capsules for adults with enteral tube feeds. Given the unidentified safety and efficacy of administration via enteral tubes, alternative alpha blockers with less selectivity for alpha1A are often used. Methods: A single center retrospective chart review was conducted at two hospital sites...
February 20, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38375585/how-do-risk-evaluation-and-mitigation-strategies-impact-clinical-practice-a-national-survey-of-physicians
#23
JOURNAL ARTICLE
Ameet Sarpatwari, Zhigang Lu, Massimiliano Russo, Heidi Zakoul, Su Been Lee, Gita A Toyserkani, Esther H Zhou, Cynthia LaCivita, Katherine Hyatt Hawkins Shaw, Laura Zendel, Gerald J Dal Pan, Aaron S Kesselheim
The US Food and Drug Administration can require risk evaluation and mitigation strategy (REMS) programs for prescription drugs to ensure the benefits of use outweigh the risks. We conducted a national survey of physicians' experiences prescribing eight REMS-covered drugs: (1) ambrisentan; (2) bosentan; (3) clozapine; (4) isotretinoin; (5-7) the multiple myeloma (MM) drugs lenalidomide, pomalidomide, thalidomide; and (8) sodium oxybate. Between May 2022 and January 2023, we surveyed 5,331 physician prescribers of these drugs, and 1,295 (24%) returned surveys (range: 149 for bosentan to 226 for MM drugs)...
February 20, 2024: Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/38299698/statin-drug-drug-interactions-pharmacokinetic-basis-of-fda-labeling-recommendations-and-comparison-across-common-tertiary-clinical-resources
#24
JOURNAL ARTICLE
James Mease, Anuradha Ramamoorthy, Xinning Yang, Rajanikanth Madabushi, Elimika Pfuma Fletcher, Issam Zineh
Statins are widely prescribed and highly susceptible to pharmacokinetic (PK)-based drug-drug interactions (DDIs). To date, there has not been a comprehensive analysis of the basis upon which statin DDI recommendations in US Food and Drug Administration (FDA) prescribing information (PI) are derived. We have conducted such an analysis. We also assessed the degree of concordance of statin DDI recommendations in FDA PI and those provided in common tertiary clinical resources. We catalogued statin DDI information, including PK data and management recommendations, for statin precipitant drugs approved from 2010 to 2021, available from FDA PI and tertiary clinical resource databases...
February 1, 2024: Journal of Clinical Pharmacology
https://read.qxmd.com/read/38291821/acceptability-preferred-medium-and-components-of-nurse-led-cardiac-telerehabilitation-a-cross-sectional-study
#25
JOURNAL ARTICLE
Chaochao Hong, Qiong Yan, Hongmei Qi, Yaoyao Zhang, Ling Yu, Lijie Dong, Jing Wang
Cardiac rehabilitation (CR) is a comprehensive and multidisciplinary secondary prevention care in coronary heart disease (CHD). There are barriers at the patient and health system levels that prevent CR from being utilized. Cardiac telerehabilitation led by nurses (Ne-CTR) can alleviate the obstacles to participation in CR. A patient perspective can improve CR access. This study was the first pre-program investigation to clarify the status of knowledge and participation in CTR. We sought to clarify the acceptability, the reasons for rejection, the desired form, components, and associated factors with the components needed for (Ne-CTR) in patients with CHD...
January 30, 2024: Clinical Nursing Research
https://read.qxmd.com/read/38289650/assessing-the-labeling-information-on-drugs-associated-with-suicide-risk-systematic-review
#26
REVIEW
Soo Min Jeon, HyunJoo Lim, Hyo-Bin Cheon, Juhee Ryu, Jin-Won Kwon
BACKGROUND: Drug-induced suicide (DIS) is a severe adverse drug reaction (ADR). Although clinical trials have provided evidence on DIS, limited investigations have been performed on rare ADRs, such as suicide. OBJECTIVE: We aimed to systematically review case reports on DIS to provide evidence-based drug information. METHODS: We searched PubMed to obtain case reports regarding DIS published until July 2021. Cases resulting from drugs that are no longer used or are nonapproved, substance use, and suicidal intentions were excluded...
January 30, 2024: JMIR Public Health and Surveillance
https://read.qxmd.com/read/38269783/development-and-usage-patterns-of-a-home-grown-drug-information-tool
#27
JOURNAL ARTICLE
Pierina Torrens, Julian Verdinelli, Luciana Rubin, Fernando Binder, Soledad Diaz, Laura Gambarte, Pilar Avila, Daniel Luna
Drug information tools help avoid medication errors, a common cause of avoidable harm in health care systems. We sought to describe the design, development process and architecture of an electronic drug information tool, as well as its overall use by health professionals. We developed a tool that can be accessed by all health professionals in a tertiary level university hospital. The functionalities of eDrugs are organized into two main parts: Drug Summary sheet, and Prescription Simulator. Most users accessed eDrugs to use the Drug summary sheet...
January 25, 2024: Studies in Health Technology and Informatics
https://read.qxmd.com/read/38269764/a-high-fidelity-combined-atc-rxnorm-drug-hierarchy-for-large-scale-observational-research
#28
JOURNAL ARTICLE
Anna Ostropolets, Polina Talapova, Marcel De Wilde, Hamed Abedtash, Peter Rijnbeek, Christian G Reich
Observational research utilizes patient information from many disparate databases worldwide. To be able to systematically analyze data and compare the results of such research studies, information about exposure to drugs or classes of drugs needs to be harmonized across these data. The NLM's RxNorm drug terminology and WHO's ATC classification serve these needs but are currently not satisfactorily combined into a common system. Creating such system is hampered by a number of challenges, resulting from different approaches to representing attributes of drugs and ontological rules...
January 25, 2024: Studies in Health Technology and Informatics
https://read.qxmd.com/read/38262485/predicting-drug-drug-interaction-with-graph-mutual-interaction-attention-mechanism
#29
JOURNAL ARTICLE
Xiaoying Yan, Chi Gu, Yuehua Feng, Jiaxin Han
Effective representation of molecules is a crucial step in AI-driven drug design and drug discovery, especially for drug-drug interaction (DDIs) prediction. Previous work usually models the drug information from the drug-related knowledge graph or the single drug molecules, but the interaction information between molecular substructures of drug pair is seldom considered, thus often ignoring the influence of bond information on atom node representation, leading to insufficient drug representation. Moreover, key molecular substructures have significant contribution to the DDIs prediction results...
January 21, 2024: Methods: a Companion to Methods in Enzymology
https://read.qxmd.com/read/38262068/analysis-of-host-cell-proteins-in-aav-products-with-proteominer-protein-enrichment-technology
#30
JOURNAL ARTICLE
Sisi Zhang, Hui Xiao, Ning Li
Despite substantial efforts to detect host cell proteins (HCPs) in antibody drugs, information regarding HCPs in gene therapy products remains limited and has not been widely integrated into the host cell engineering or purification processes. Most methods that have successfully detected HCPs in antibody drugs are not applicable to gene therapy products, except for the ProteoMiner enrichment method. Here, we demonstrate that ProteoMiner beads effectively enrich HCPs in adeno-associated virus (AAV) products and simultaneously remove the detergent Pluronic F-68 without a loss of low-abundance HCPs...
January 23, 2024: Analytical Chemistry
https://read.qxmd.com/read/38255118/identification-of-barriers-for-active-disease-management-and-of-medication-related-problems-through-therapeutic-patient-education-in-older-home-care-patients
#31
JOURNAL ARTICLE
Sabrina Grigolo, Barbara Bruschi, Diego Di Masi, Carla Bena, Lucrezia Greta Armando, Clara Cena
Combining therapeutic patient education (TPE) with a medication review service could foster the adoption of appropriate lifestyles by patients and support care-providers in identifying strategies to improve the quality of prescribed care. This study aimed to identify barriers experienced by patients in managing their diseases and medication-related problems. This was a monocentric, case series, observational study involving home-care patients from the Local Health Authority ASL TO4. Patients were enrolled for a TPE intervention where drug therapies and patient habits were collected through narrative interviews...
January 17, 2024: Healthcare (Basel, Switzerland)
https://read.qxmd.com/read/38246272/benefit-of-clinical-pharmacists-in-neurology-clinics-at-an-academic-medical-center
#32
JOURNAL ARTICLE
Bethany Anderson, Melissa J Snider, Margaret Hansen, Caitlin Parks, Aaron Bagnola, Junan Li, Miriam Freimer, Benjamin Segal
BACKGROUND: Patients with neurologic diseases have complex medical needs and may benefit from the addition of clinical pharmacists in their care OBJECTIVES: The aim of this study was to describe integration and benefit of clinical pharmacists in neuroimmunology and neuromuscular clinics at an academic medical center. METHODS: This retrospective chart review evaluated patients initiated on a neurology medication for a neuroimmunology or neuromuscular disease state prior to and after pharmacist integration in neurology clinics...
January 19, 2024: Journal of the American Pharmacists Association: JAPhA
https://read.qxmd.com/read/38242565/efficacy-of-non-pharmacological-interventions-for-primary-dysmenorrhoea-a-systematic-review-and-bayesian-network-meta-analysis
#33
JOURNAL ARTICLE
Xinglin Li, Xinyu Hao, Jian-Hua Liu, Jian-Peng Huang
OBJECTIVES: To assess the relative benefits of various non-pharmacological interventions on treating primary dysmenorrhoea within a network meta-analysis. STUDY DESIGN: Systematic review and Bayesian network meta-analysis. INCLUSION CRITERIA: Randomised controlled trial involving patient with primary dysmenorrhoea and received non-pharmacological interventions. DATA SOURCES: Four databases (Medline, Embase, Cochrane Library and Web of Science) were searched from inception to October first, 2022...
January 19, 2024: BMJ Evidence-Based Medicine
https://read.qxmd.com/read/38240599/hydroxychloroquine-induced-hypoglycemia-in-a-patient-without-diabetes
#34
JOURNAL ARTICLE
Madison Mcknight, B Tate Cutshall, Sami Sakaan, Nisreen Abu Al Hommos, Drew A Wells
Hydroxychloroquine is a disease-modifying antirheumatic drug commonly used in the treatment of autoimmune diseases. Although rare, hydroxychloroquine is associated with hypoglycemia in patients with or without diabetes due to its ability to alter insulin metabolism. There have been several cases described in the literature, but none of which, to our knowledge, detail follow-up and time to resolution of hypoglycemia. We describe a 55-year-old female who presents for episodes of hypoglycemia. She reported hypoglycemic symptoms and fasting blood glucoses in the 60-70s mg/dL regularly...
January 19, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38230387/utilizing-chatgpt-in-telepharmacy
#35
JOURNAL ARTICLE
Firas H Bazzari, Amjad H Bazzari
BACKGROUND: ChatGPT is an artificial intelligence-powered chatbot that has demonstrated capabilities in numerous fields, including medical and healthcare sciences. This study evaluates the potential for ChatGPT application in telepharmacy, the delivering of pharmaceutical care via means of telecommunications, through assessing its interactions, adherence to instructions, and ability to role-play as a pharmacist while handling a series of life-like scenario questions. METHODS: Two versions (ChatGPT 3...
January 2024: Curēus
https://read.qxmd.com/read/38226348/a-survey-of-drive-thru-pharmacy-services-evaluating-the-acceptance-and-perspectives-of-community-pharmacists-in-saudi-arabia
#36
JOURNAL ARTICLE
Ibrahim M Asiri, Dina Y Alrastal, Rawan K Alaqeel, Fawaz M Alotaibi, Sawsan M Kurdi, Dhafer M Alshayban, Mohammed M Alsultan, Bassem A Almalki, Bashayer M AlShehail, Wafa A ALZlaiq, Mansour M Alotaibi, Muteb S Alanazi
BACKGROUND: The practice of dispensing drugs in primary healthcare centers has shifted to community pharmacies in Saudi Arabia. These changes increase demand and mandate improving their services; one such is establishing pharmacy drive-thru services. To explore the effects of drive-thru services on the pharmacy profession, this study aimed to measure community pharmacists' acceptance, perception, and satisfaction regarding drive-thru services. METHODS: This cross-sectional study design was conducted in Saudi Arabia between January 2023 and May 2023-comparing the perception, acceptance, and satisfaction of pharmacists who work in a community pharmacy that provides a drive-thru service versus no drive-thru service...
January 2024: Saudi Pharmaceutical Journal: SPJ: the Official Publication of the Saudi Pharmaceutical Society
https://read.qxmd.com/read/38221892/generic-pharmaceuticals-regulatory-aspects-bioequivalence-investigation-and-perception
#37
REVIEW
Ravi Bhushan, Jürgen Martens
INTRODUCTION: The objective and significance of the topic is to draw attention toward regulatory aspects (and pharmacopoeias) for bioequivalence investigation, and perception for generic pharmaceuticals, especially their stereoselective bioequivalence evaluation for understanding the performance of the racemic generic products available in the market. AREAS COVERED: The areas covered include bioequivalence studies (and related USP and FDA requirements) on certain generic APIs for comparison, examples of concern related to inspection of pharmaceuticals for export/import...
January 15, 2024: Expert Opinion on Drug Safety
https://read.qxmd.com/read/38108407/silencing-the-fda-s-voice-drug-information-on-trial
#38
JOURNAL ARTICLE
Tina Watson, Christopher Robertson
New England Journal of Medicine, Volume 389, Issue 25, Page 2312-2314, December 2023.
December 16, 2023: New England Journal of Medicine
https://read.qxmd.com/read/38106923/medicine-and-pharmacy-students-knowledge-attitudes-and-practice-regarding-artificial-intelligence-programs-jordan-and-west-bank-of-palestine
#39
JOURNAL ARTICLE
Rami Mosleh, Qais Jarrar, Yazun Jarrar, Mariam Tazkarji, Mohammed Hawash
BACKGROUND: Artificial intelligence (AI) programs generate responses to input text, showcasing their innovative capabilities in education and demonstrating various potential benefits, particularly in the field of medical education. The current knowledge of health profession students about AI programs has still not been assessed in Jordan and the West Bank of Palestine (WBP). AIM: This study aimed to assess students' awareness and practice of AI programs in medicine and pharmacy in Jordan and the WBP...
2023: Advances in Medical Education and Practice
https://read.qxmd.com/read/38105007/lack-of-information-on-gender-differences-in-the-package-inserts-of-prescription-drugs-in-japan
#40
JOURNAL ARTICLE
Narumi Maida, Shingo Kondo, Masanori Ogawa, Naoko Hayashi, Hiroki Iwata, Noriko Kobayashi, Katsunori Yamaura
The package inserts of prescription drugs provide essential information for the proper administration of pharmacotherapy. The incidence of adverse reactions for several drugs is known to be higher in women than in men. However, no studies have examined whether information on gender differences is included in Japanese package inserts. Therefore, this study investigated information on gender differences in the package inserts of Japanese prescription drugs, using the drug information database JAMES provided by the Medical Information System Development Center and the Japan Pharmaceutical Information Center...
December 15, 2023: Drug Discoveries & Therapeutics
keyword
keyword
24127
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.